Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.03 -0.18 (-1.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (2018 - 2026)

Updated

Arcturus Therapeutics Holdings' Cash & Equivalents came in at $191.48 million for Q2 2026, down 2.5% from $196.47 million a year earlier and down 9.4% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcturus Therapeutics Holdings' Cash & Equivalents was $230.91 million, down 21.4% from FY2024.

  • Cash & Equivalents carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $293.91 million in FY2024 (+0.7%), $292.01 million in FY2023 (-25.5%), $391.88 million in FY2022 (+5.8%) and $370.49 million in FY2021 (-20.0%).
  • The five-year range for quarterly Cash & Equivalents is $180.36 million (Q3 2025) to $413.88 million (Q3 2021).
  • Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 15.4% over the last eight quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 34.8%), and the weakest in Q3 2022 (a decline of 42.6%).
  • Business Quant data shows ARCT's Cash & Equivalents at $211.38 million (Q1 2026), $230.91 million (Q4 2025) and $180.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Arcturus Therapeutics Holdings 375.47 Mn -438.66 Mn - 191.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191.48 Mn
Mar 31, 2026 211.38 Mn
Dec 31, 2025 230.91 Mn
Sep 30, 2025 180.36 Mn
Jun 30, 2025 196.47 Mn
Mar 31, 2025 216.95 Mn
Dec 31, 2024 293.91 Mn
Sep 30, 2024 237.18 Mn
Jun 30, 2024 260.33 Mn
Mar 31, 2024 288.40 Mn
Dec 31, 2023 292.01 Mn
Sep 30, 2023 311.92 Mn
Jun 30, 2023 323.47 Mn
Mar 31, 2023 327.94 Mn
Dec 31, 2022 391.88 Mn
Sep 30, 2022 237.68 Mn
Jun 30, 2022 283.49 Mn
Mar 31, 2022 319.68 Mn
Dec 31, 2021 370.49 Mn
Sep 30, 2021 413.88 Mn
API Access

Arcturus Therapeutics Holdings Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARCT&period=max&api_key=YOUR_API_KEY